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the Delta neutrophil index predicts 
the Development of in-hospital 
Hypotension in initially Stable 
patients with pyogenic Liver 
Abscess
taeyoung Kong1, Yoo Seok park1, Hye Sun Lee  2, Sinae Kim2, Jong Wook Lee3, Je Sung You  1, 
Hyun Soo chung1, incheol park1 & Sung phil chung1
prompt diagnosis and timely treatment are important for reducing morbidity and mortality from 
pyogenic liver abscess (pLA). the purpose of this study was to investigate the importance of the 
delta neutrophil index (DNI) reflecting the fraction of immature granulocytes as a predictor of the 
development of in-hospital hypotension in initially stable patients with pLA. We retrospectively 
identified 308 consecutive patients (>18 years) who were hemodynamically stable at presentation and 
diagnosed with PLA in the emergency department (ED) between January 2011 and September 2017. 
The outcome of interest was in-hospital hypotension 1–24 hours after admission to the ED. A high DNI 
at eD admission was an independent predictor of the development of in-hospital hypotension in initially 
stable patients with PLA (odds ratio [OR]: 1.44, 95.0% confidence interval [CI]: 1.06–1.95; P = 0.02). A 
Dni > 3.3% was associated with in-hospital hypotension at ED admission (OR: 5.37, 95.0% CI: 2.91–
9.92; P < 0.001). The development of in-hospital hypotension was associated with an increased risk 
of 30-day mortality (HR: 8.55, 95.0% CI: 2.57–28.4; P < 0.001). A high DNI independently predicts the 
development of in-hospital hypotension in initially stable patients with pLA. in-hospital hypotension is 
associated with an increased risk of 30-day mortality.
Although pyogenic liver abscess (PLA) is uncommon, its incidence is increasing worldwide1. PLA is more preva-
lent in Asian countries than in Western countries2. Recent significant increases in incidence in the United States 
may be explained by the increasing aging population, diabetes, hepatobiliary disease, instrumental usage of the 
biliary tract, and liver transplantation3.
In the 1930s, PLA was considered a potentially life-threatening condition, with mortality rates of up to 77.0%4. 
The current mortality rate of PLA has markedly reduced to 6.0–14.0%5. Despite advances in diagnostic and ther-
apeutic techniques, PLA remains a critical illness with significant morbidity and mortality rates5. As early and 
appropriate applications of intravenous antibiotics and catheter drainage are the main therapies for PLA, prompt 
diagnosis and timely treatment are most important for PLA4,6. Although these patients have stable hemodynam-
ics in the early stages of PLA, delays in appropriate diagnosis and treatment can lead to the rapid development 
of septic shock2. Septic shock is significantly associated with tissue hypoperfusion, increased development of 
organ failure, and eventual mortality2,7. Therefore, prompt and accurate risk stratification for the development of 
in-hospital hypotension in initially stable patients with PLA plays a key role in improving outcomes2. However, 
it is difficult to predict the development of in-hospital hypotension in patients with PLA based on several known 
prognostic indicators.
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Recent technological advances enable us to determine the delta neutrophil index (DNI), reflecting the fraction 
of circulating immature granulocytes, using a specific automated blood cell analyzer8–11. The DNI, measured by 
an automated blood cell analyzer, is strongly associated with manually counted immature granulocytes12. The 
DNI overcomes the disadvantages of manually counting immature granulocytes and can aid in predicting infec-
tion severity in early stages13. An increase in circulating immature granulocytes, as well as a leftward granulocytic 
shift, are well-known to be associated with infection and systemic inflammation8–11,14,15. Several studies12,13 have 
reported that a high DNI reflecting an increase in the fraction of immature granulocytes is significantly associated 
with a positive blood culture test result, the development of septic shock, disseminated intravascular coagulation, 
and mortality in critically ill patients with suspected sepsis.
To the best of our knowledge, few studies have investigated the usefulness of biomarkers in predicting the 
development of in-hospital hypotension, and this is the first study to evaluate the relationship between DNI and 
the development of in-hospital hypotension in initially hemodynamically stable patients with PLA. We investigate 
the importance of DNI as a predictor of the development of in-hospital hypotension in initially stable patients 
with PLA.
Results
Study population, clinical evaluation, and treatment. The inclusion and clinical outcomes of the 
initially stable patients with PLA (n = 308; 63[55–71] years) are shown in Fig. 1. Sixty-one patients (19.8%) devel-
oped in-hospital hypotension. The 30-day mortality rate was 3.9%. Twelve of the 308 patients (3.9%) died within 
30 days after ED admission because of septic shock after PAL (n = 8), hepatic failure due to hepatocellular car-
cinoma (n = 1), aggravation of cholangiocarcinoma (n = 1) and pancreatic cancer (n = 1), and unexpected car-
diac arrest during endoscopy (n = 1). Patients were initially treated with empirical intravenous broad-spectrum 
antibiotics. Percutaneous drainage was performed in 204 patients (66.2%). Surgical intervention was performed 
in 6 patients (1.9%) (Table 1). Isolated bacterial characteristics are shown in Table 2. The present study identified 
Klebsiella pneumoniae as the most common pathogen in blood (n = 74, 24%) and pus (n = 104, 49.5%) cultures. 
Among the patients with K. pneumoniae in the blood, 20 of 74 had malignancy of the gastrointestinal tract. 
These malignancies included hepatocellular carcinoma (n = 6), pancreatic cancer (n = 4), stomach cancer (n = 3), 
duodenal cancer (n = 1), ampulla of vater cancer (n = 1), cholangiocarcinoma (n = 4), and colon cancer (n = 1). 
Furthermore, 24 of the 104 patients with K. pneumoniae in pus had malignancy of the gastrointestinal tract. By 
type, they had hepatocellular carcinoma (n = 5), gallbladder cancer (n = 4), pancreatic cancer (n = 2), stomach 
cancer (n = 2), duodenal cancer (n = 1), ampulla of vater cancer (n = 2), cholangiocarcinoma (n = 5), rectal can-
cer (n = 1), and colon cancer (n = 2).
Liver abscess patients
(2011.1.1-2017.9.30)
N= 705 
 Exclusion (N=397)
• Amebic liver abscess (2)
• Infected biloma (2)
• Under treatment (139)
• Transfer from another hospital (70)
• Other infections are combined (66)
• Haematologic malignancy (12)
• Chemotherapy within 7 day (6)
• Discharge / Transfer out in ED (15)
• Unstable patients (85)
  Systolic blood pressure ≤ 90 mmHg or 
  Mean arterial pressure ≤ 65 mmHg or
  Lactate ≥ 4mmol/L or
  Intravenous infusion of catecholamine  
  at admission
In-hospital hypotension (+)
N61 (19.8%)
In-hospital hypotension (-)
N247 (80.2%)
Death within 30 day 
N=8
Survival 
N=53
Death within 30 day
N=4
Survival 
N=243
Final patients analyzed in this study
N 308 
Figure 1. Flow chart of patient enrolment.
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Dni as a predictor of in-hospital hypotension in initially stable patients with pLA. Distribution 
of delta neutrophil index (DNI) according to development of in-hospital hypotension are shown in Supplement 1. 
The DNI vale was higher in patients with in-hospital hypotension than in those without in-hospital hypotension 
(Table 1). Univariable logistic regression analysis revealed that the DNI was significantly different at ED admis-
sion between those who did and did not develop in-hospital hypotension (Supplement 2). In the multivariable 
logistic regression analysis, a high DNI at ED admission was also an independent predictor of the development 
of in-hospital hypotension in initially stable patients with PLA (odds ratio [OR]: 1.44, 95.0% confidence interval 
[CI]: 1.06–1.95; P = 0.02) (Table 3). The AUROC for predicting in-hospital hypotension using the DNI at ED 
admission in initially stable patients with PLA was 0.746 (P < 0.001) (Fig. 2). Using Youden’s index, the opti-
mal cutoff value for the DNI at ED admission was 3.3% (sensitivity, 70.5 [59–81.9]; specificity, 69.2 [63.5–75]). 
A DNI > 3.3% was significantly associated with in-hospital hypotension at ED admission (OR: 5.37, 95.0% CI: 
2.91–9.92; P < 0.001) (Fig. 2). Kaplan-Meier curves showed a significant association between in-hospital hypo-
tension and 30-day mortality (Hazard ratio (HR): 8.55, 95.0% CI: 2.57–28.4; P < 0.001) in initially stable patients 
with PLA (Fig. 3).
Variables Total N = 308 (100%)
Development of in-hospital hypotension
No N = 247 (80.2%) Yes N = 61 (19.8%) P
Age (years) 63 [55–71] 62 [54–71] 66 [56–73] 0.09
Male gender [n (%)] 192 (62.34) 155 (62.75) 37 (60.66) 0.76
qSOFA score (point) 0 [0–1] 0 [0–1] 1 [0–1] <0.01*
Initial vital sign
MBP (mmHg) 85 [77–96] 87 [78–98] 78 [73–87] <0.01*
Heart rate (bpm) 96 [85–108] 94 [83–106] 105 [95–120] <0.01*
Body temperature (°C) 37.7 [36.9–38.7] 37.6 [36.8–38.5] 38.3 [37.1–39.2] 0.01*
Radiology features
Size of abscess (cm) 5 [3.3–6.8] 5 [3.3–6.8] 5 [3.4–6.5] 0.91
Multiple lesions [n (%)] 94 (30.5) 74 (30) 20 (32.8) 0.67
Bilobar involvement [n (%)] 47 (15.3) 35 (14.2) 12 (19.7) 0.29
Treatment modality [n (%)] 0.15
Antibiotic only 98 (31.8) 81 (32.8) 17 (27.9)
Antibiotics + Percutaneous drainage 204 (66.2) 163 (66) 41 (67.2)
Antibiotics + Surgical treatment 6 (2) 3 (1.2) 3 (4.9)
Timing of treatment
Door to antibiotic time (hour) 3.98 [2.88–5.13] 3.98 [2.83–5.2] 3.93 [3.15–5.08] 0.88
Door to intervention time (hour) 15.84 [4.97–38.24] 15.72 [4.83–27.82] 17.02 [5.3–80.65] 0.12
Comorbidity [n (%)]
Hypertension 120 (38.96) 96 (38.87) 24 (39.34) 0.95
Diabetes mellitus 84 (27.27) 67 (27.13) 17 (27.87) 0.91
Chronic kidney disease 7 (2.27) 4 (1.62) 3 (4.92) 0.14
Malignancy 121 (39.29) 92(37.25) 29 (47.54) 0.14
Liver cirrhosis 9 (2.92) 5 (2.02) 4 (6.56) 0.08
Cardiovascular disease 29([9.42) 22 (8.91) 7(11.48) 0.54
Laboratory data
WBC count (10^3/μL) 11.11 [7.66–15.23] 11.36 [8.32–15.06] 8.96 [6.04–15.35] 0.11
Hemoglobin (g/dL) 12.15 [10.7–13.4] 12.2 [10.8–13.5] 11.7 [10.5–13.2] 0.37
Platelet count (10^3/μL) 178 [124–272] 192 [136–301] 132 [88–198] <0.01*
Neutrophil ratio (%) 85.4 [79.9–89.5] 83.95 [79.05–88.2] 89.5 [85.4–93] <0.01*
Prothrombin ratio (%) 80 [69–93] 80 [70–95] 79 [66–89] 0.2
Creatinine (mg/dL) 0.85 [0.65–1.08] 0.8 [0.63–1.01] 1.02 [0.81–1.5] <0.01*
Albumin (g/dL) 3.2 [2.8–3.6] 3.2 [2.8–3.6] 2.9 [2.7–3.4] 0.01*
ALT (IU/L) 40 [25–74] 38 [24–66] 56 [27–96] 0.02*
Total bilirubin (mg/dL) 1.1 [0.7–1.7] 0.9 [0.6–1.6] 1.3 [1–2.4] <0.01*
C reactive protein (mg/L) 169 [95–234] 165 [90–228] 197 [134–266] 0.02*
Lactate (mmol/L) 1.75 [1.1–2.8] 1.3 [1–2] 2.6 [1.6–4.8] <0.01*
Bacteremia [n (%)] 111 (36) 64 (25.9) 47 (77.1) <0.01*
DNIa 0.9 [−0.29–1.61] 0.74 [−0.69–1.44] 1.79 [0.99–2.73] <0.01*
Table 1. Clinical characteristics of patients according to the development of in-hospital hypotension. *P < 0.05, 
Data are expressed in median [IQR] and n (%), aVariable was logarithmically transformed before analyses. 
Abbreviations: qSOFA, quick sequential organ failure assessment; MBP, mean blood pressure; WBC, white 
blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; DNI, delta neutrophil index.
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Pathogen
Blood 
(N = 308) Pus (N = 210)
Klebsiella pneumoniae 74 (24%) 104 (49.5%)
Escherichia coli 9 (2.9%) 19 (9.0%)
Streptococcus species 5 (1.6%) 11 (5.2%)
Staphylococcus species 0 (0%) 2 (1.0%)
Enterococcus species 2 (0.6%) 5 (2.4%)
Enterobacter species 5 (1.6%) 4 (1.9%)
Clostridium species. 2 (0.6%) 2 (1.0%)
Anaerobes 6 (1.9%) 5 (2.4%)
Others 8 (2.6%) 2 (1.0%)
No growth 197 (64%) 56 (26.7%)
Table 2. Bacterial isolates from 308 patients with pyogenic liver abscess.
Variable
Multivariable logistic regression
OR (95% CI) P
qSOFA score 2.453 (1.451–4.147) 0.004*
Heart rate (per 1bpm) 1.030 (1.011–1.050) 0.004*
Body temperature (per 1 °C) 1.314 (0.939–1.837) 0.075
Platelet count (per 10^3/μL) 0.996 (0.993–0.999) 0.012*
Neutrophil ratio (per 1%) 0.990 (0.946–1.036) 0.657
Prothrombin time (per 1%) 0.993 (0.972–1.016) 0.555
Albumin (per 1 g/dL) 0.656 (0.326–1.319) 0.237
ALT (per 1IU/L) 1.003 (0.999–1.007) 0.186
Total bilirubin (per 1 mg/dL) 1.009 (0.906–1.125) 0.866
C reactive protein (per 1 mg/L) 1.001 (0.997–1.005) 0.584
DNIa (per 1%) 1.437 (1.058–1.953) 0.020*
Table 3. Multivariable logistic regression analysis of predictors for the development of in-hospital 
hypotension. *P < 0.05, aVariable was logarithmically transformed before analyses. Abbreviations: ALT, alanine 
aminotransferase; DNI, delta neutrophil index; qSOFA, quick sequential organ failure assessment.
Figure 2. ROC curves of the DNI for predicting the development of in-hospital hypotension. DNI, delta 
neutrophil index; ROC, receiver operating characteristic.
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comparison of the Dni and conventional clinical markers as predictors of in-hospital hypoten-
sion in initially stable patients with pLA. To predict the development of in-hospital hypotension, com-
parisons of the ROC curves showed that the AUROC for the DNI at ED admission was significantly superior to 
that of other markers (C-reactive protein [CRP], white blood cell count [WBC], neutrophil-to-lymphocyte ratio 
[NLR], and absolute neutrophil count [ANC]). Moreover, the DNI value was not significantly inferior to those of 
other markers, including qSOFA scores at ED admission (Fig. 4 and Supplement 3).
prognostic value of the Dni in combination with conventional risk factors. Integrated discrim-
ination improvement (IDI) and net reclassification improvement (NRI) are proposed indicators for identifying 
improvement of reclassification in a nested model, showing how predictive power improves when DNI is added 
to traditional risk factors. The addition of DNI yielded a significantly positive IDI and NRI for the prediction of 
in-hospital hypotension. However, no significant improvement was observed in the AUC when DNI was added to 
the predictive model of in-hospital hypotension composed of traditional risk factors (Table 4 and Supplement 4).
Figure 3. The development of in-hospital hypotension as a predictor of 30-day mortality.
Figure 4. Comparison of the ROC curves of the DNI and other laboratory markers for predicting the 
development of in-hospital hypotension. Abbreviations: DNI, delta neutrophil index; ROC, receiver operating 
characteristic; WBC, white blood cell; N/L, neutrophil/lymphocyte; ANC, absolute neutrophil count; CRP, 
C-reactive protein; qSOFA, Quick Sequential Organ Failure Assessment.
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Comparison of 30-day mortality between groups according to treatment modality in patients with 
higher Dni values. In the present study, the 30-day mortality rates of total patients and those with DNI ≤ 3.3% 
were 3.9% and 1.6%, respectively. However, that of patients with DNI > 3.3% was 7.6%. On analyzing 30-day mor-
tality according to treatment modality in patients with DNI > 3.3%, we found a mortality rate of 17.4% in patients 
who received only antibiotics; in contrast, patients who were managed with aggressive treatment, including antibiotic 
therapy with percutaneous drainage or surgical intervention, had a mortality rate of 5.2%. However, this difference was 
not significant between the two groups (p = 0.069). In patients with DNI < 3.3%, there was no difference between the 
two groups (1.3% vs. 1.8%) according to the treatment modality (p > 0.999) (Supplement 5). Clinical characteristics of 
the patients in our study according to the treatment modality are shown in Supplement 6. Initially stable patients with 
PLA who received aggressive treatment had a higher cumulative survival rate than those who received conservative 
management [hazard ratio (HR): 0.277, 95.0% CI: 0.051–0.1.508; P = 0.04] in (Supplement 7).
External validation of cut-off value. In total, 155 patients were included in the validation cohort during 
the study period (Supplement 8). Twenty-two patients (14.2%) developed in-hospital hypotension. The 30-day 
mortality rate was 3.2%. When the cut-off of the study cohort was applied to the validation cohort, the sensi-
tivity and specificity were 81.8% (95% CI, 65.7–97.9) and 54.1% (95% CI, 45.7–62.6), respectively, in predict-
ing in-hospital hypotension. DNI values ≥ 3.3% at ED admission (OR, 5.31; 95% CI: 1.71–16.54; p < 0.001) also 
remained significantly associated with an increased risk of in-hospital hypotension in the validation cohort.
Discussion
The present study demonstrated that a high DNI at ED admission was an independent predictor of the develop-
ment of in-hospital hypotension in initially stable patients with PLA. DNI > 3.3% at ED admission was signif-
icantly associated with in-hospital hypotension. The development of in-hospital hypotension in initially stable 
patients with PLA was closely associated with an increased 30-day mortality. Despite patients having initially 
stable hemodynamics, the development of shock or in-hospital hypotension in initially stable patients with PLA 
substantially increases mortality and is associated with serious complications, such as acute kidney injury and 
acute respiratory distress syndrome2.
A previous study4 reported that the development of shock in patients with PLA increased mortality up to 
22-fold and extended the length of hospitalization, whilst consuming a substantial amount of healthcare 
resources. In initially stable patients with PLA, our study suggested that the development of in-hospital hypoten-
sion was closely associated with increased 30-day mortality. Furthermore, a reliable study16 showed that mortal-
ity was associated with the duration of hypotension before the commencement of antibiotic treatment. Hence, 
accurate risk stratification of the development of in-hospital hypotension is a prerequisite for improving patient 
prognosis through appropriate therapy, including rapid antibiotic administration, urgent abscess drainage, and 
professional interventions16.
Recently, Cho et al.2 reported older age, malignancy, lower SBP, tachypnea, and increased lactate and pro-
calcitonin to be predictors of the development of shock in initially stable patients with PLA. Although the Cho 
et al.2 study identified clinical predictors of shock, which can be determined readily at the bedside, the authors 
did not suggest optimal cutoff values for several predictors. Therefore, these may be difficult to apply directly to 
clinical practice. In the present study, the DNI was also found to be an independent predictor of the development 
of in-hospital hypotension. A DNI ≥ 3.3% at ED admission was associated with a significantly increased risk of 
developing in-hospital hypotension in initially stable patients with PLA.
Prediction model
Incremental value of DNI added to predictive model composed of traditional risk factors
AUROC  
(95% CI)
Difference of 
AUROC (95% CI) P
NRI  
(95% CI) P
IDI  
(95% CI) P
(A)
Reference (Ref.) 
model
0.814  
(0.750–0.879)
Ref. model + DNIa 0.819  (0.754–0.884)
0.005  
(−0.022–0.031) 0.731
0.127 
(0–0.254) 0.049*
0.027 
(0.004–0.05) 0.023*
(B)
Prediction model
Comparison between predictive model composed of traditional risk factors and traditional risk factors combined with DNI
Sensitivity (95% CI) P
Specificity 
(95% CI) P
Accuracy 
(95% CI) P
NPV  
(95% CI) P
PPV  
(95% CI) P
Ref. model 72.1 (60.9–83.4) Ref. 81.4 (76.5–86.3) Ref.
79.5 
(75–84.1) Ref.
49.4 
(39.1–59.8) Ref.
92.1 
(88.4–95.7) Ref.
Ref. model + DNIa 63.9 (51.9–76) 0.020 90.1 (86.3–93.8) <0.001
84.8  
(80.8–88.9) 0.001
61.9 
(49.9–73.9) <0.001
90.8 
(87.2–94.5) 0.170
Table 4. Comparison of the predictive performance of the in-hospital hypotension with and without 
the delta neutrophil index (DNI). *P < 0.05, aVariable was logarithmically transformed before analyses. 
Abbreviations: AUROC, area under the receiver operating characteristic; CI, confidence interval; DNI, delta 
neutrophil index; IDI, integrated discrimination improvement; NRI, net reclassification index; PPV, positive 
predictive value; NPV, negative predictive value; Reclassification tables comparing two prediction models (See 
Supplement 4). Reference model = qSOFA score + Heart rate + Body temperature + Platelet count + Neutrophil 
ratio + Prothrombin ratio + Serum albumin level + Serum alanine aminotransferase level + Total 
bilirubin + C-reactive protein.
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To date, there have been relatively few clinical studies of prognostic factors for PLA due to its relatively low 
prevalence and mortality3. Kuo et al.17 reported that Mortality in Emergency Department Sepsis (MEDS) scores 
at ED admission are a significant predictor of mortality in initially stable patients with PLA. MEDS scores include 
clinical signs, such as shock and tachycardia. Therefore, it is unclear whether MEDS scores can predict severity, 
even before the appearance of clinical symptoms17. Acute Physiology and Chronic Health Evaluation II scores 
have been useful in several studies5,18 for predicting the outcome of patients admitted to the intensive care unit 
(ICU). However, Acute Physiology and Chronic Health Evaluation II scores, originally designed to measure dis-
ease severity in patients admitted to the ICU, are based on complex laboratory data. Therefore, at the time of ED 
admission, its use does not seem feasible17,19.
The DNI reflecting the fraction of circulating immature granulocytes in the blood has the additional benefit 
of being automatically analyzed along with the CBC, which is routinely and rapidly determined in critically ill 
patients without additional time, cost, and equipment, unlike CRP, lactate, and procalcitonin15. Given the simplic-
ity of the measurement and its cost effectiveness, our findings suggest that DNI could be a promising predictor 
of in-hospital hypotension in initially stable patients with PLA. Previous studies have reported that a high DNI 
is significantly associated with poor outcomes in patients with specific disease conditions and can predict the 
severity of infectious diseases. Although we cannot directly compare the different studies, their findings suggest 
that a high DNI may be positively associated with a higher disease severity. Park et al.13 demonstrated that a DNI 
of >6.5% was a promising diagnostic marker of severe sepsis and septic shock in the first 24 hours of admission 
to an ICU. Similar to our findings, a high DNI was present up to 12 hours before the onset of circulatory or organ 
failure13. Furthermore, Yune et al.15 reported a DNI of >8.4% on Day 1 (HR: 3.23) and a DNI of >10.5% on Day 
2 (HR: 3.29) as being associated with a significant increase in 30-day mortality in patients with out-of-hospital 
cardiac arrest. The present study showed that DNI ≥ 3.3% at ED admission was significantly associated with 
in-hospital hypotension (OR: 5.37).
Previous studies20,21 have proposed several pathogenic hypotheses to elucidate the mechanism underlying the 
release of immature granulocytes in the early stages of sepsis. In poorly controlled local infection and systemic 
microbial infection, neutrophils are in high demand and need to be regenerated in large numbers. Hence, severe 
systemic infection can switch from steady-state granulopoiesis to emergency granulopoiesis, which is character-
ized by considerably enhanced de novo generation of neutrophils22. DNI may be associated with an increased 
cellular turnover and a rapid release of mature and immature granulocytes from bone marrow into the peripheral 
blood22,23. Guerin et al.21 revealed that sepsis was associated with an increased frequency of circulating IGs, which 
was a good predictive value for sepsis deterioration 48 hours after admission. This finding was in agreement with 
our data, which showed that DNI reflecting the IG count could be closely associated with the deterioration in 
patients with PLA.
Klebsiella pneumoniae infection has been shown to be an independent predictor of the development of septic 
shock in initially stable patients with PLA24. A previous study by Cho et al.2 identified Klebsiella pneumoniae as 
the most common pathogen in blood (22.8%) and pus (54.1%) cultures. Our findings are consistent with the 
results of previous Asian studies. However, the disadvantage that it takes a long time to obtain the results and 
bacteria cannot be detected in culture may be an obstacle to its clinical applicability for predicting the severity of 
PLA.
Law et al.25 evaluated the effectiveness of the WBC, ANC, and CRP level as biomarkers for predicting the treat-
ment outcomes of initially stable patients with PLA. The WBC has a low diagnostic performance for infection 
due to leukopenia in immunocompromised patients with infection and several coexisting noninfectious factors25. 
Despite its cost effectiveness, the rapid reduction in CRP levels was useful for predicting favorable outcomes and 
the adequacy of antibiotic therapy in initially stable patients with PLA25. A recent study26 reported that the NLR 
was associated with a significantly poorer prognosis in patients with PLA. The present study showed that the DNI 
at ED admission had similar predictability as qSOFA scores. Moreover, the DNI at ED admission was superior 
to the WBC, ANC, CRP level, and NLR for predicting the development of in-hospital hypotension. Integrated 
discrimination improvement (IDI) and net reclassification improvement (NRI) are proposed indicators for iden-
tifying improvement of reclassification in a nested model, showing how predictive power improves when DNI is 
added to traditional risk factors. The addition of DNI yielded a significantly positive IDI and NRI for the predic-
tion of in-hospital hypotension. The present study suggests that DNI can be an ancillary tool to help determine 
the modality for treatment. Future prospective, multicenter studies with a larger number of patients are needed to 
validate the usefulness of the DNI for determining the adequacy of treatment and as a marker of appropriate time 
points for urgent intervention in initially stable patients with PLA.
This study has several limitations. First is its retrospective design based on the inclusion of a patient cohort 
derived from a single, tertiary, academic hospital. Therefore, there is the potential for selection bias due to the 
difficulty in controlling for confounding factors. Second, although our hospital endeavored to standardize treat-
ment for PLA, the prognosis may have varied due to the individual administration of antibiotics to patients with 
different pathogens and the different time points at which intervention or surgery for urgent abscess drainage 
was required. Third, although the present study demonstrated that development of in-hospital hypotension was 
associated with increased 30-day mortality, careful attention should be paid while interpreting these results due 
to the relatively low incidence of PLA mortality (3.9%) in our study. Finally, Pencina et al.27 suggested that NRI 
values of <0.2, 0.2–0.6, and >0.6 should be considered weak, intermediate, and strong, respectively. In this study, 
the NRI value on adding DNI to the model composed of traditional risk factors was approximately 0.127 (95% CI: 
0–0.254), showing weak reclassification ability according to the above criteria. Therefore, we should be cautious 
while clinically applying DNI. However, considering the practicality and cost-effectiveness of DNI, it may still be 
clinically valuable in patients with PLA, despite the weak NRI observed in the present study.
We found that a high DNI value independently predicts development of in-hospital hypotension within 
24 hours of admission in initially stable patients with PLA. DNI is measured at the same time as CBC. It has the 
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advantage of being an easy and rapid measurement. Therefore, the addition of DNI to traditional predictors may 
serve as a promising ancillary test for rapid risk stratification in initially stable patients with PLA. We suggest 
that physicians be more attentive toward initially stable patients with PLA showing high DNI values. Future pro-
spective, multicenter studies with larger patient populations are needed to validate the usefulness of DNI as an 
independent or ancillary predictor, by adding DNI to several other traditional predictors in evaluating initially 
stable patients with PLA.
Methods
Study population. We conducted a retrospective, observational study in the emergency department (ED) 
of Yonsei University College of Medicine Severance Hospital (Seoul, Republic of Korea), a university-affiliated, 
tertiary-level referral hospital with an annual census of approximately 85,000 visits. The study was reviewed 
and approved by the Institutional Review Board of Yonsei University Health System (Seoul, Republic of Korea) 
(approval no.: 3-2017-0303). The need for written informed consent was waived because of the retrospective 
study design.
We retrospectively identified 308 consecutive patients (>18 years) who were hemodynamically stable at pres-
entation and diagnosed with PLA who were admitted to the ED between January 1, 2011 and September 30, 2017. 
The data of patients who were diagnosed with PLA during a single admission to the ED and had a final diagnosis 
of PLA (International Classification of Diseases, 10th edition code, K75.0) based on diagnostic or therapeutic 
techniques performed in the ED were retrospectively analyzed. PLA was defined if at least one of the following 
criteria was present: (1) positive culture of liver aspirate or surgical sample from a discrete liver abscess; (2) diag-
nostic imaging findings consistent with a liver abscess with a concurrent positive blood culture; and (3) diagnostic 
imaging findings consistent with a liver abscess with a defined radiological and clinical response to antimicrobial 
management, even if blood cultures were negative or not performed2,28.
The primary endpoint was the development of in-hospital hypotension. To investigate the development of 
in-hospital hypotension, we excluded patients if they had hypotension (defined as systolic blood pressure [SBP] 
<90 mmHg, or mean arterial pressure <65 mmHg, or the need for intravenous catecholamine infusion) or an 
elevated lactate level of ≥4.0 mmol/L at ED admission2. Other exclusion criteria included patients referred from 
other hospitals after commencing antimicrobial therapy, those with amoebic liver abscess or infected biloma, 
those receiving chemotherapy within 7 days, and those with a history of previous or current hematological 
malignancy2,8.
In-hospital hypotension was defined as sepsis-induced hypotension (SBP <90.0 mmHg, or mean arterial pres-
sure <65.0 mmHg, or a reduction in SBP of >40.0 mmHg from baseline) persisting for >60 minutes without 
signs of hypovolemia (bleeding, dehydration, vomiting, diarrhea, or adverse drug effects) or cardiac dysfunction 
1–24 hours after admission to the ED2,7,29. Radiological studies were performed in patients with suspected septic 
shock in the ED. These patients were treated with empirical broad-spectrum antibiotics immediately after clinical 
diagnosis2. Patients who developed intractable hypotension during hospitalization were treated according to the 
revised early goal-directed therapy protocol for critical care, including fluid resuscitation and organ support30.
Data collection. The electronic medical records of all patients diagnosed with PLA were reviewed. Data 
were collected on demographic characteristics (age; sex; prior medical history, including hypertension, diabe-
tes, liver cirrhosis, chronic kidney disease, cardiovascular disease, and malignancy; hemodynamic parameters; 
laboratory test results; radiological findings, including abscess size; in-hospital course and clinical outcome, 
including the development of in-hospital hypotension and 30-day mortality; the main type of treatment 
received; and the period of follow-up). The DNI for each patient was determined using venous blood collected in 
ethylenediaminetetraacetic-containing vacutainers at ED admission (within 15 minutes of admission to the ED). 
To assess the DNI, the same type of hematology analyzer (ADVIA 2120; Siemens, Forchheim, Germany) was used 
as that for the analysis of complete blood counts (CBCs). Quick sequential organ failure assessment (qSOFA) 
scores were measured at admission to the ED to evaluate the clinical severity of each patient.
Dni measurements. The specific analyzer performs DNI measurements using two different systems based 
on a cytochemical myeloperoxidase tungsten-halogen channel and a laser diode channel8–10. The cytochemical 
myeloperoxidase tungsten-halogen channel measures and differentiates neutrophils, eosinophils, lymphocytes, 
monocytes, and large unstained cells based on size and myeloperoxidase staining intensity8–10. The laser diode 
channel calculates, classifies, and counts cell types according to lobularity/nuclear density and size8–10,12. The 
DNI is then calculated by subtracting the fraction of mature polymorphonuclear neutrophils from the sum of the 
myeloperoxidase-reactive cells, detecting circulating immature granulocytes as the leukocyte subfraction11–13.
Statistical analyses. Data were assessed for normality using the Kolmogorov-Smirnov test. Demographic 
and clinical data are presented as the median and interquartile range, mean ± standard deviation, or percentage 
and frequency, as appropriate. Continuous variables were compared using a 2-sample t-test or the Mann-Whitney 
U test. Categorical variables were compared using the Chi-square test or Fisher’s exact test. Because of the skew-
ness of the histogram of the DNI distribution, the DNI was transformed as natural logarithm of DNI value plus 
1 before analyses. Multivariable logistic regression analysis was performed to examine the relationship between 
DNI and the development of in-hospital hypotension. The results of the multivariable logistic regression analysis 
are presented as odds ratios (ORs) and 95% confidence intervals (CIs).
Areas under the receiver operating characteristic (ROC) curves (AUROCs) were used to assess the ability of 
the DNI to predict the development of hypotension using ROC curves. The optimal cutoff value for the DNI was 
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determined using Youden’s index. Kaplan-Meier survival curves were also plotted using 30-day mortality data. 
The hypotension and non-hypotension groups were compared using the log-rank test.
ROC curves were constructed to assess the diagnostic performance of the DNI and other clinical parameters. 
AUROCs were calculated and compared using the Delong method. Integrated discrimination improvement (IDI) 
and net reclassification improvement (NRI) were evaluated to analyze the extent to which the addition of the DNI 
to the reference model improved predictability. To determine 95.0% CIs and P-values for IDI and NRI, a standard 
bootstrap method was used with resampling performed 1,000 times.
To identify significant relationships between treatment modality and 30-day mortality, conservative man-
agement using only antibiotics and aggressive treatments, including antibiotics and percutaneous drainage or 
surgical intervention, were compared using Kaplan-Meier survival curves and the log-rank test.
To validate the cut-off points in this study, the external validation was retrospectively conducted with a vali-
dation cohort collected between January 2010 and July 2014 at Yonsei University College of Medicine, Gangnam 
Severance Hospital (Seoul, Republic of Korea), which attends to 50,000 patients in the ED annually. We collected 
all data of the validation cohort according to the inclusion and exclusion criteria of this study.
All statistical analyses were conducted using SAS software (version 9.2; SAS Institute Inc., Cary, NC, USA), 
R software for Windows (version 3.2.5; the R foundation for statistical computing, Vienna, Austria [http://
www.R-project.org/]), and MedCalc (version 12.7.0; MedCalc Software, Ostend, Belgium). A P < 0.05 was con-
sidered statistically significant.
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